The unfolded protein response is a potential therapeutic target in pathogenic fungi
The FEBS Journal · 2025
DOI: 10.1111/febs.70100 ↗At a glance
Übersichtsarbeit in The FEBS Journal, 2025. Written by Hao Zhou and 5 co-authors. Institution: School of Basic Medical Sciences, Southwest Medical University, Luzhou, China. Major MEDLINE topics: Unfolded Protein Response, Fungi, Antifungal Agents, Mycoses. Cited 7 times so far (Crossref); 152 references. Funded by: Sichuan Science and Technology Program, Technology Strategic Cooperation Project of Luzhou Municipal People's Government Southwest Medical University, Luzhou City Science and Technology Plan Key Projects.
Abstract (original language)
Pathogenic fungal infections cause significant morbidity and mortality, particularly in immunocompromised patients. The frequent emergence of multidrug‐resistant strains challenges existing antifungal therapies, driving the need to investigate novel antifungal agents that target new molecular moieties. Pathogenic fungi are subjected to various environmental stressors, including pH, temperature, and pharmacological agents, both in natural habitats and the host body. These stressors elevate the risk of misfolded or unfolded protein production within the endoplasmic reticulum (ER) which, if not promptly mitigated, can lead to the accumulation of these proteins in the ER lumen. This accumulation triggers an ER stress response, potentially jeopardizing fungal survival. The unfolded protein response (UPR) is a critical cellular defense mechanism activated by ER stress to restore the homeostasis of protein folding. In recent years, the regulatory role of the UPR in pathogenic fungi has garnered significant attention, particularly for its involvement in fungal adaptation, regulation of virulence, and drug resistance. In this review, we comparatively analyze the UPRs of fungi and mammals and examine the potential utility of the UPR as a molecular antifungal target in pathogenic fungi. By clarifying the specificity and regulatory functions of the UPR in pathogenic fungi, we highlight new avenues for identifying potential therapeutic targets for antifungal treatments.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- School of Basic Medical Sciences, Southwest Medical University, Luzhou, China.
- Public Center of Experimental Technology, Southwest Medical University, Luzhou, China.
- Hemodynamics and Medical Engineering Combination Key Laboratory of Luzhou, China.
ORCID profiles: Zhangyong Song
Funding
- Sichuan Science and Technology Program
- Technology Strategic Cooperation Project of Luzhou Municipal People's Government Southwest Medical University
- Luzhou City Science and Technology Plan Key Projects
Cite
APA
Zhou, H., Zhang, J., Wang, R., Huang, J., Xin, C., & Song, Z. (2025). The unfolded protein response is a potential therapeutic target in pathogenic fungi. The FEBS Journal. https://doi.org/10.1111/febs.70100
Vancouver
Zhou H, Zhang J, Wang R, Huang J, Xin C, Song Z. The unfolded protein response is a potential therapeutic target in pathogenic fungi. The FEBS Journal. 2025. doi:10.1111/febs.70100
BibTeX
@article{Zhou2025,
author = {Zhou, Hao and Zhang, Jinping and Wang, Rong and Huang, Ju and Xin, Caiyan and Song, Zhangyong},
title = {The unfolded protein response is a potential therapeutic target in pathogenic fungi},
journal = {The FEBS Journal},
year = {2025},
doi = {10.1111/febs.70100}
}
EUVIMED